Does coronary angioplasty after timely thrombolysis improve microvascular perfusion and left ventricular function

Luciano Agati1, Stefania Funaro, Mariapina Madonna

  • 1Department of Cardiology, La Sapienza University, Rome, Italy. luciano.agati@uniroma1.it

Insights

Early percutaneous coronary intervention (PCI) after thrombolysis for ST-segment elevation myocardial infarction (STEMI) preserves heart function better than lysis alone. This approach offers a valuable alternative when primary PCI is not immediately available.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Research

Background:

  • Emerging data suggest percutaneous coronary intervention (PCI) is superior to no PCI or ischemia-guided PCI in stable ST-segment elevation myocardial infarction (STEMI) post-thrombolysis.
  • The pathophysiologic basis for these findings requires elucidation.
  • This study investigates whether complete mechanical recanalization of the infarct-related artery enhances clinical benefits by improving coronary microcirculation.

Purpose of the Study:

  • To test the hypothesis that improved microvascular perfusion following complete mechanical reperfusion contributes to better clinical outcomes in STEMI patients.
  • To compare the effects of primary PCI, thrombolysis with subsequent PCI, and thrombolysis alone on microvascular function and myocardial salvage.

Main Methods:

  • Analysis of 96 STEMI patients randomized within 3 hours of symptom onset.
  • Groups included primary PCI (n=36), tenecteplase followed by PCI within 24 hours (n=30), and tenecteplase alone (n=30).
  • Microvascular perfusion assessed by myocardial contrast echocardiography; various cardiac function parameters evaluated at multiple time points.

Main Results:

  • No significant differences in baseline characteristics between groups.
  • Similar microvascular damage and myocardial salvage in primary PCI and post-lysis PCI groups.
  • Thrombolysis alone (Group C) resulted in greater microvascular damage, larger infarct size, and depressed left ventricular function compared to PCI-treated groups.

Conclusions:

  • Early PCI following thrombolysis is more effective in preserving myocardial perfusion and function than thrombolysis alone.
  • This strategy represents a beneficial alternative when primary PCI is not accessible for STEMI patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...